<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26658876</article-id>
<article-id pub-id-type="pmc">6605504</article-id>
<article-id pub-id-type="publisher-id">3967-14</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.3967-14.2015</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kogan</surname>
<given-names>Jeffrey H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gross</surname>
<given-names>Adam K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Featherstone</surname>
<given-names>Robert E.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shin</surname>
<given-names>Rick</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Qian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heusner</surname>
<given-names>Carrie L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adachi</surname>
<given-names>Megumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Amy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walton</surname>
<given-names>Noah M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyoshi</surname>
<given-names>Sosuke</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyake</surname>
<given-names>Shinichi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tajinda</surname>
<given-names>Katsunori</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ito</surname>
<given-names>Hiroyuki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Siegel</surname>
<given-names>Steven J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Matsumoto</surname>
<given-names>Mitsuyuki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Neuroscience, Astellas Research Institute of America LLC, Skokie, Illinois 60077, </aff>
<aff id="aff2"><sup>2</sup>Bioimaging Research, Translational Science Research Labs, and </aff>
<aff id="aff3"><sup>3</sup>Neuroscience Research Unit, Research Portfolio and Science, Drug Discovery Research, Astellas Pharma, Inc., Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan, and </aff>
<aff id="aff4"><sup>4</sup>Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Mitsuyuki Matsumoto, PhD,
<addr-line>Neuroscience Research Unit, Drug Discovery Research, Astellas Pharma, Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.</addr-line><email>mitsuyuki.matsumoto@astellas.com</email></corresp>
<fn fn-type="con">
<p>Author contributions: J.H.K., A.K.G., R.E.F., R.S., Q.C., C.L.H., M.A., S. Miyoshi, H.I., S.J.S., and M.M. designed research; J.H.K., A.K.G., R.E.F., R.S., Q.C., C.L.H., M.A., A.L., N.M.W., S. Miyake, K.T., S.J.S., and M.M. performed research; J.H.K., R.E.F., S. Miyoshi, and M.M. contributed unpublished reagents/analytic tools; J.H.K., A.K.G., R.E.F., R.S., Q.C., C.L.H., M.A., A.L., N.M.W., S. Miyake, K.T., H.I., S.J.S., and M.M. analyzed data; J.H.K., R.E.F., M.A., S.J.S., and M.M. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="FN1">
<p>*J.H.K. and A.K.G. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>9</day>
<month>12</month>
<year>2015</year>
</pub-date>
<volume>35</volume>
<issue>49</issue>
<fpage>16282</fpage>
<lpage>16294</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>9</month>
<year>2014</year>
</date>
<date date-type="rev-recd">
<day>2</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2015 the authors 0270-6474/15/3516282-13$15.00/0</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="zns04915016282.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The chromosome 15q13.3 microdeletion is a pathogenic copy number variation conferring epilepsy, intellectual disability, schizophrenia, and autism spectrum disorder (ASD). We generated mice carrying a deletion of 1.2 Mb homologous to the 15q13.3 microdeletion in human patients. Here, we report that mice with a heterozygous deletion on a C57BL/6 background (D/+ mice) demonstrated phenotypes including enlarged/heavier brains (macrocephaly) with enlarged lateral ventricles, decreased social interactions, increased repetitive grooming behavior, reduced ultrasonic vocalizations, decreased auditory-evoked gamma band EEG, and reduced event-related potentials. D/+ mice had normal body weight, activity levels, sensory gating, and cognitive abilities and no signs of epilepsy/seizures. Our results demonstrate that D/+ mice represent ASD-related phenotypes associated with 15q13.3 microdeletion syndrome. Further investigations using this chromosome-engineered mouse model may uncover the common mechanism(s) underlying ASD and other neurodevelopmental/psychiatric disorders representing the 15q13.3 microdeletion syndrome, including epilepsy, intellectual disability, and schizophrenia.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Recently discovered pathologic copy number variations (CNVs) from patients with neurodevelopmental/psychiatric disorders show very strong penetrance and thus are excellent candidates for mouse models of disease that can mirror the human genetic conditions with high fidelity. A 15q13.3 microdeletion in humans results in a range of neurodevelopmental/psychiatric disorders, including epilepsy, intellectual disability, schizophrenia, and autism spectrum disorder (ASD). The disorders conferred by a 15q13.3 microdeletion also have overlapping genetic architectures and comorbidity in other patient populations such as those with epilepsy and schizophrenia/psychosis, as well as schizophrenia and ASD. We generated mice carrying a deletion of 1.2 Mb homologous to the 15q13.3 microdeletion in human patients, which allowed us to investigate the potential causes of neurodevelopmental/psychiatric disorders associated with the CNV.</p>
</abstract>
<kwd-group>
<kwd>15q13.3</kwd>
<kwd>autism</kwd>
<kwd>CNV</kwd>
<kwd>epilepsy</kwd>
<kwd>intellectual disability</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>